PF-07220060 (CDK4/6-IN-6) Mechanism of Action: CDK4 Inhibition in Breast Cancer Cell Research

PF-07220060 (CDK4/6-IN-6) MOA：Targeting CDK4/Cell Cycle Pathway for HR+/HER2- Metastatic Breast Cancer

🎯 check PF-07220060 (CDK4/6-IN-6) product page

PF-07220060 is a selective CDK4/6 inhibitor. It blocks the cell cycle by inhibiting pRB1 phosphorylation, halting tumor growth.

Primary Applications and Mechanism of Action

Jump to: